CYP4V2 fatty acid omega hydroxylase, a druggable target for the treatment of metabolic associated fatty liver disease (MAFLD)
Nicholas J. Osborne, Charles Leahy, Yoon‐Kwang Lee, Paula Rote, Byoung‐Joon Song, James P. Hardwick
Topics & Concepts
Arachidonic acidBiochemistryBiologyPolyunsaturated fatty acidMetabolismFatty acidChemistryEnzymeAdipose Tissue and MetabolismLipid metabolism and biosynthesisLiver Disease Diagnosis and Treatment